Commercial Kidney Donation and the Ethical Burden of Socioeconomic Vulnerability: A Clinical Perspective From Iran

As a nurse working within the Iranian health care system, I have witnessed a troubling ethical landscape around living kidney donation—one in which economic desperation, rather than altruism, is the principal motivator for many donors. Iran operates the world’s only regulated system of paid living unrelated kidney donation, but this framework raises profound ethical concerns about donor vulnerability and exploitation. Drawing on clinical experience and ethical analysis, this editorial examines how socioeconomic pressures drive some Iranians to sell a kidney and why this constitutes a systemic injustice that demands urgent attention from the global medical and ethical community.

In daily practice, health care professionals encounter young men, often in their twenties or early thirties, who present themselves as kidney donors not because they voluntarily seek to help recipients but because financial hardship has left them with no alternative. Empirical evidence from a regulated kidney market in Mashhad, Iran, supports this clinical observation: the average donor is 29.9 years old, 85% are male, and donors had an average of approximately 8 years of education; the study also characterized donors as generally financially motivated.¹ In my clinical experience, Their narratives frequently include statements such as “I need money to pay rent,” “I am unemployed,” or “I have to pay off debt.” These stories reveal a profound ethical paradox: what is legally framed as “donation” is, in reality, a transaction shaped by social and economic pressures that undermine the very concept of informed and voluntary consent. The commercialization of kidney donation raises concerns about the extent to which choices made under severe financial hardship can be considered fully autonomous, particularly when individuals resort to selling a kidney to cope with poverty, debt, or unemployment.²

Nurses, who are intimately involved in the perioperative care of both donors and recipients, experience considerable moral distress. Although nurses are educated to advocate for autonomy, dignity, and justice, the reality of financially motivated kidney donation stands in opposition to these core ethical principles. Donor autonomy is profoundly undermined when the choice to undergo an invasive, irreversible surgical procedure is driven not by voluntary decision-making but by economic necessity. This concern is substantiated by empirical evidence indicating that 68% of kidney donors in Iran reported feeling coerced into donation because of extreme poverty or familial pressures.³ This raises a critical ethical question for the global medical community: Can consent be authentically voluntary when the individual faces severe economic deprivation?

Moreover, the commercialization of kidney donation creates and perpetuates socioeconomic asymmetries. Wealthier recipients, who can afford the costs associated with transplantation, gain access to a life-saving organ, whereas poorer individuals become the suppliers.¹ Moreover, the commercialization of kidney donation raises ethical concerns about socioeconomic inequality and the vulnerability of individuals who may resort to selling a kidney out of financial desperation. Such circumstances raise questions about the extent to which consent can be considered genuinely voluntary when economic necessity constrains an individual's available choices.⁴ This dynamic transforms the bodies of financially vulnerable populations into resources that sustain the lives of the more affluent. From an ethical perspective, this constitutes a form of exploitation—one that is normalized by systemic inequalities and insufficient social support.³ Table 1 summarizes the key ethical tensions identified in this clinical context.

Table 1.

Key ethical tensions in commercial kidney donation from a clinical perspective

Ethical principle	Clinical observation	Ethical concern
Autonomy	Donors cite financial necessity rather than free choice	Consent is compromised by economic coercion
Beneficence	Recipients gain life-saving transplants	Donor well-being is neglected
Nonmaleficence	Donors experience postoperative pain, reduced capacity, regret	Harm is foreseeable and often unmitigated
Justice	Wealthier recipients, poorer donors	Systemic inequality is perpetuated
Dignity	Donors describe themselves as “selling a part of themselves”	Commodification of the human body

Health care workers, particularly nurses, witness both sides of this injustice. Although transplantation undeniably offers hope and survival to recipients, the long-term consequences for donors are often neglected. Many donors experience postoperative pain, reduced physical capacity, psychological distress, or regret, particularly when the financial relief they sought proves temporary.^5,6 In a study of 30 Iranian kidney donors, the lowest quality reported of life scores was for emotional role functioning (mean 54.44/100), followed by mental health (64.26/100) and social functioning (66.25/100).⁶ Similarly, Zargooshi reported that 85% of kidney sellers would definitely not sell a kidney again if given another chance, while 66% reported very negative financial effects.⁵ Without adequate follow-up and support, donors may face worsened socioeconomic and health conditions in the long term.⁷ The ethical tension here is profound: a life is saved; however, another life may be diminished.

The current regulatory framework fails to adequately address the structural determinants that drive individuals toward organ selling. Although formal guidelines emphasize informed consent and medical screening, they do not sufficiently account for the coercive power of financial desperation. This gap highlights the need for a broader ethical debate—one that moves beyond technical regulation to confront the underlying social injustice that makes commercial kidney donation possible.

From an ethics standpoint, several measures are essential:

• 1.Enhanced psychosocial assessment that evaluates economic coercion as part of the consent process.
• 2.Long-term medical and psychological follow-up for donors, funded by national health programs.
• 3.Policies to reduce financial incentives, such as expanding deceased donor programs and improving public education.
• 4.National-level strategies to address poverty and unemployment that push individuals toward selling an organ.

Nurses hold a unique moral and professional position in this debate. As the health care workers closest to patients, we are often the first to recognize the vulnerability of donors and the exploitation embedded in their experiences. Our role extends beyond clinical care to include advocacy, ethical vigilance, and bearing witness to injustice. Remaining silent in the face of such inequity would contradict the core values of our profession.⁸

The issue of financially motivated kidney donation in Iran must be understood not merely as a national phenomenon, but as a global ethical challenge. It highlights the consequences of unmet social needs, insufficient health care justice, and inadequate protection for vulnerable populations. By raising this issue in the international ethical community, nurses can help catalyze meaningful dialogue and policy reform—ensuring that organ donation remains aligned with principles of dignity, autonomy, and equity.

Author Contributions

SAR contributed to the conception and design of the study, literature review, drafting of the manuscript, and final approval of the version to be published.